Skip to main content
Premium Trial:

Request an Annual Quote

We Call It the Brainiac Gene

Daniel MacArthur posts the highlights from last Friday's sessions at AGBT from Kari Stefansson, John Todd, and Richard Gibbs. Stefansson discussed some unpublished data from Decode, including type 2 diabetes variants that affect a person's risk differently based on whether they are maternally or paternally inherited, as well as a genetic region associated "with a love of crossword puzzles." Todd presented on a gene, IFIH1 with a strong association with a risk of type 1 diabetes and Gibbs talked about the role of rare variants in disease risk. According to MacArthur, Gibbs was genotyped by a personal genomics company and found the information "completely useless."

MacArthur also followed up on his post about Complete Genomics, having spoken to the company's CEO Clifford Reid and CSO Rade Drmanac over the weekend. He goes into more depth about the company's technical approach and business model here.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.